- Home
- PRCT vs FISN Comparison
PRCT vs FISN Comparison
Compare PRCT & FISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$19.32
Company Overview
Basic Information| Metric | PRCT | FISN |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 930.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRCT | FISN |
|---|---|---|
| Price | $19.32 | $10.40 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $35.44 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 438.9K |
| Earning Date | 04-29-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,054,000.00 | N/A |
| Revenue This Year | $31.34 | N/A |
| Revenue Next Year | $24.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.22 | N/A |
| 52 Week Low | $17.96 | $7.66 |
| 52 Week High | $60.57 | $15.50 |
Technical Indicators
Market Signals| Indicator | PRCT | FISN |
|---|---|---|
| Relative Strength Index (RSI) | 35.81 | 43.62 |
| Support Level | N/A | $9.70 |
| Resistance Level | $29.27 | $12.32 |
| Average True Range (ATR) | 1.45 | 1.17 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 20.51 | 41.52 |
Price Performance
Historical Comparison PRCT
FISN
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.